← FDA Drug Approvals (Drugs@FDA)

TIGECYCLINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2019-06-11

Drug application

FDA Application #
ANDA206335
Application type
Abbreviated New Drug Application (Generic)
Brand name
TIGECYCLINE
Generic name
TIGECYCLINE
Active ingredients
TIGECYCLINE
Dosage form
POWDER
Route
INTRAVENOUS
Marketing status
Prescription
Sponsor
EUGIA PHARMA
Manufacturer
Eugia US LLC
First approval
2019-06-11

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown